Keywords: serono, ivax, initiate, ph, iii, ms, trial

Serono and IVAX to initiate Ph III MS trial

Article | 24 January 2005

Print This

Under an agreement signed in 2002, Swiss biotechnology group Serono and the USA's IVAX have unveiled plans to start a Phase ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in